LCADP - Clinical: Adenovirus, Molecular Detection, PCR, Plasma

Test Catalog

Test Name

Test ID: LCADP    
Adenovirus, Molecular Detection, PCR, Plasma

Useful For Suggests clinical disorders or settings where the test may be helpful

An aid in diagnosing adenovirus infections

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Human adenoviruses cause a variety of diseases including pneumonia, cystitis, conjunctivitis, diarrhea, hepatitis, myocarditis, and encephalitis. In humans, adenoviruses have been recovered from almost every organ system. Infections can occur at any time of the year and in all age groups. Currently, there are 51 adenovirus serotypes that have been grouped into 6 separate subgenera.


Culture is the gold standard for the diagnosis for adenovirus infection; however, it can take up to 3 weeks to achieve culture results. Mayo's shell vial culture provides more rapid results, reported at 2 and 5 days. While PCR offers a rapid, specific, and sensitive means of diagnosis by detecting adenovirus DNA.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.


Interpretation Provides information to assist in interpretation of the test results

A positive result indicates the presence of adenovirus nucleic acid.


A negative result does not rule out the presence of adenoviruses because organisms may be present at levels below the detection limits of this assay.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Test results should be used as an aid in diagnosis and should not be considered diagnostic in themselves.


Although the reference range is generally considered to be "Negative" for this assay, adenovirus DNA may be detected from asymptomatic individuals in certain settings. This assay should only be used to test patients with clinical history and symptoms consistent with adenovirus disease, and is not used to screen healthy patients.

Supportive Data

The following data support the use of this assay for clinical testing.


Accuracy/Diagnostic Sensitivity and Specificity:

A study of 791 clinical specimens compared shell vial culture and this PCR assay. Included in the study were 288 swab specimens (nasal, throat, rectal, skin), 125 eye specimens, 221 respiratory specimens (bronchial washings, sputa, bronchioalveolar lavage, tracheal secretions), 56 fresh tissue specimens, 72 stools, and 29 body fluids/other specimens. Specimens were inoculated into culture tubes and examined for cytopathic effects over a period of 14 days, and subsequently assayed with this LightCycler assay. Comparison of cell culture with LC PCR yielded the following: total specimens positive by LC PCR was 76 (stool=6; respiratory=7; tissue=3; swabs=28; eye specimens=29; urine=2; miscellaneous = 1) and total specimens by culture were 52 (stool= 8; respiratory=3; tissue=3; swabs=23; eye specimens=13; urine=2). Of the 76 total positive specimens, PCR produced a 13.5% increased rate of detection of adenovirus compared with culture. Analytical sensitivity was assessed by testing dilutions (in triplicate) of the plasmid control down to a level corresponding to 1 target/microliter. The limit of reproducible detection was determined to be 10 targets/microliter. Additionally, the sensitivity of plasma was known to be > or =90% at the concentration of 10 targets/microliter. This assay detected all 51 serotypes of adenovirus tested.


Supplemental Data (Spiking Studies):

To supplement the above data, 30 negative samples of various types (cerebrospinal fluid, ocular, respiratory, stool, urine, and plasma) were spiked with adenovirus positive control plasmid at the limit of detection (approximately 10 targets/microliter). The 30 spiked specimens were run in a blinded manner with 30 negative (non-spiked) specimens. 100% of the spiked specimens were positive and 100% of the nonspiked specimens were negative.


Analytical Sensitivity/Limit of Detection (LoD):

The lower limit of detection of this assay is 10 targets/microliter in specimen matrix.


Analytical Specificity:

No PCR signal was obtained from extracts of 150 bacterial, viral, parasitic, and fungal isolates that could cause similar disease or could be found as normal flora in sites normally tested for this organism.



Interassay precision was 100% and intra-assay precision was 100%.


Reference Range:

The reference range for this assay is "Negative."


Reportable Range:

This is a qualitative assay and results are reported as negative or positive for targeted adenovirus DNA.

Clinical Reference Recommendations for in-depth reading of a clinical nature

1. Ebner K, Pinsker W, Lion T: Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol 2005;79:12635-12642

2. Ebner K, Suda M, Watzinger F, Lion T: Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J Clin Microbiol 2005;43:3049-3053

3. Jothikumar N, Cromeans TL, Hill VR, et al: Quantitative real-time PCR assays for the detection of human adenoviruses and identification of serotypes 40 and 41. Appl Environ Microbiol 2005;71:3131-3136

4. Robinson C, Echavarria M: Adenovirus. In Manual of Clinical Microbiology. Edited by PR Murray, EJ Baron, JH, et al: Washington, DC, ASM Press, 2007, pp 1589-1600

5. Thavagnanam S, Christie SN, Doherty GM, et al: Respiratory viral infection in lower airways of asymptomatic children. Acta Paediatr 2010 Mar;99(3):394-398

6. Kaneko H, Maruko I, Iida T, et al: The possibility of human adenovirus detection in the conjunctiva in asymptomatic cases during a nosocomial infection. Cornea 2008 Jun;27(5):527-530